Authors:
Zhou, JY
Golay, X
van Zijl, PCM
Silvennoinen, MJ
Kauppinen, R
Pekar, J
Kraut, M
Citation: Jy. Zhou et al., Inverse T-2 contrast at 1.5 tesla between gray matter and white matter in the occipital lobe of normal adult human brain, MAGN RES M, 46(2), 2001, pp. 401-406
Authors:
Haroun, RI
Guarnieri, M
Meadow, JJ
Kraut, M
Carson, BS
Citation: Ri. Haroun et al., Current opinions for the treatment of syringomyelia and Chiari malformations: Survey of the Pediatric Section of the American Association of Neurological Surgeons, PED NEUROS, 33(6), 2000, pp. 311-317
Authors:
Sandler, AB
Kindler, HL
Einhorn, LH
Mitchell, E
Masters, G
Kraut, M
Nicol, S
Raghavan, D
Citation: Ab. Sandler et al., Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction, ANN ONCOL, 11(9), 2000, pp. 1161-1164
Citation: V. Calhoun et al., A weighted least-squares algorithm for estimation and visualization of relative latencies in event-related functional MRI, MAGN RES M, 44(6), 2000, pp. 947-954
Authors:
Luoto, R
Manolio, T
Meilahn, E
Bhadelia, R
Furberg, C
Cooper, L
Kraut, M
Citation: R. Luoto et al., Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, whitematter changes, and brain atrophy in older women: The Cardiovascular Health Study, J AM GER SO, 48(5), 2000, pp. 467-472
Authors:
Murray, N
Livingston, RB
Shepherd, FA
James, K
Zee, B
Langleben, A
Kraut, M
Bearden, J
Goodwin, JW
Grafton, C
Turrisi, A
Walde, D
Croft, H
Osoba, D
Ottaway, J
Gandara, D
Citation: N. Murray et al., Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group, J CL ONCOL, 17(8), 1999, pp. 2300-2308